Stay updated on Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.

Latest updates to the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.3.3) was added and the old revision (v3.3.2) plus the HHS Vulnerability Disclosure link were removed. These are minor metadata updates that do not affect the study record content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe history now includes a new revision entry v3.3.2 and removes the previous revision v3.3.1.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page history now includes a new revision labeled v3.3.1 and removes the previous revision v3.2.0.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved the funding-lapse notice that warned information may not be up to date and that inquiries might not be answered until appropriations are enacted. It also removed details about the NIH Clinical Center status and the links to cc.nih.gov and opm.gov.SummaryDifference0.2%

- Check65 days agoChange DetectedThe record history now contains multiple new entries documenting repeated Study Status updates on various dates, expanding the revision log of the trial record.SummaryDifference0.1%

- Check93 days agoChange Detected- Added a government funding lapse notice and operating status information for NIH Clinical Center with a link to cc.nih.gov and opm.gov updates. - Updated software version from v3.1.0 to v3.2.0.SummaryDifference6%

Stay in the know with updates to Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.